Who
Diem Nguyen
Director
Company insider
Files Form 4 as: Director, Candel Therapeutics; Director, Verrica Pharmaceuticals; Chief Executive Officer, SIGA Technologies.
In numbers
- Trades disclosed
- 43
- Buys
- 1
- Sells
- 0
- Bought
- $80K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 9 Jun 2020
- Last trade
- 23 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | VRCA Verrica Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | VRCA Verrica Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —85,045 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $247K47,029 at $5.26 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —85,045 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —85,045 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —272,243 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —272,243 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —85,045 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $247K47,029 at $5.26 | filing |
| 27 Jan 2026filed 28 Jan 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —55,902 at $0.00 | filing |
| 27 Jan 2026filed 28 Jan 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $156K22,804 at $6.82 | filing |
| 27 Jan 2026filed 28 Jan 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —55,902 at $0.00 | filing |
| 27 Jan 2026filed 28 Jan 2026 | SIGA SIGA Technologiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —55,902 at $0.00 | filing |
| 27 Jan 2026filed 28 Jan 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code M | —55,902 at $0.00 | filing |
| 27 Jan 2026filed 28 Jan 2026 | SIGA SIGA TechnologiesPharmaceuticals | SEC FORM 4 Code F | $156K22,804 at $6.82 | filing |
| 17 Jun 2025filed 18 Jun 2025 | CADL Candel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,240 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | VRCA Verrica Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.